This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864–870.
Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907–913.
List AF, Vardiman J, Issa JP, DeWitte TM . Myelodysplastic syndromes. Hematol Am Soc Hematol Educ Program 2004, 297–317.
Yamamoto K, Abe S, Nakagawa Y, Suzuki K, Hasegawa M, Inoue M et al. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leuk Res 2004; 28: 1203–1211.
Sugimoto K, Hirano N, Toyoshima H, Chiba S, Mano H, Takaku F et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 1993; 81: 3022–3026.
Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R . p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Am J Pathol 1994; 145: 338–344.
Dash A, Gilliland DG . Molecular genetics of acute myeloid leukaemia. Best Pract Res Clin Haematol 2001; 14: 49–64.
Nakada S, Katsuki Y, Imoto I, Yokoyama T, Nagasawa M, Inazawa J et al. Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations. J Clin Invest 2006; 116: 80–89.
Acknowledgements
We thank Ms Inoue and Ms Hasegawa for technical assistance. This work was supported by a Grant-in-aid from the Ministry of Education, Science and Culture. MT is supported by a Grant-in-aid from Japanese Leukemia Research Fund.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Horibe, S., Takagi, M., Unno, J. et al. DNA damage check points prevent leukemic transformation in myelodysplastic syndrome. Leukemia 21, 2195–2198 (2007). https://doi.org/10.1038/sj.leu.2404748
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404748